Author: Author: dcridigital

The M.D. Program at Icahn School of Medicine

The M.D. Program at Icahn School of Medicine combines the most progressive, technologically advanced, scientifically-based education with the goal of improving societal health care needs locally in New York City and around the world. We explicitly blur the traditional distinction between pre-clinical and clinical years by integrating the basic sciences across courses as well initiating students into to the clinical environment from their first day of school.Not only do our students acquire the medical, scientific and clinical expertise needed for a successful career, but also the skills to work in interdisciplinary teams, the analytic tools needed for research, the confidence to critically evaluate and apply new information, an appreciation for the social, ethical and cultural aspects of health and the life-enriching skills they require to become self-directed, life-long learners.

JAMA highlights IGNITE sites’ work to integrate genomic testing in routine care

Posted: July 12, 2017

Journal of the American Medical Association – University of Maryland’s Dr. Toni Pollin and Duke University’s Drs. Geoff Ginsburg and Lori Orlando discuss how their programs are working to improve care through genetic testing in areas such as diagnosing monogenic diabetes and using family history to identify patients’ personal disease risks.

News Archive

Happenings, accomplishments and milestones of the IGNITE Network and its affiliates

JAMA highlights IGNITE sites’ work to integrate genomic testing in routine care

Posted: July 12, 2017

Journal of the American Medical Association – University of Maryland’s Dr. Toni Pollin and Duke University’s Drs. Geoff Ginsburg and Lori Orlando discuss how their programs are working to improve care through genetic testing in areas such as diagnosing monogenic diabetes and using family history to identify patients’ personal disease risks.

IGNITE Network analysis of challenges to implementing genomics in practice featured on GenomeWeb

Posted: June 21, 2017

GenomeWeb – Duke University led this effort to identify key challenges to and potential solutions for implementing genomics in practice based on information from IGNITE’s six member projects. (A free subscription is required to view this article.)

IGNITE Network highlighted at Precision Medicine World Conference 2017

Posted: June 8, 2017

BioQuick News – Duke University’s Dr. Geoffrey Ginsburg, co-chair and speaker at the 2017 Precision Medicine World Conference, presented the IGNITE Network’s achievements and aspirations to advance the implementation of genomics in practice.

IGNITE sites present at the 2017 Genomic Medicine X: PGx Meeting

Posted: May 5, 2017

IGNITE’s Drs. Todd Skaar, Josh Denny, Larisa Cavallari, and Kristin Weitzel were session speakers at the Genomic Medicine X: Research Directions in Pharmacogenomics Implementation Meeting on May 2 -3, 2017.

University of Maryland offers genomics education course using students’ own genomes

Posted: March 28, 2017

Association of American Medical Colleges – To help future clinicians better understand the importance of using genomics in practice, University of Maryland College of Medicine students can choose to study parts of their own genomes, or anonymous genomes, in a course all medical students are required to take.

IGNITE Network’s Kristin Weitzel quoted in AAMC story on the growth of genetics in medical education

Posted: January 24, 2017

Association of American Medical Colleges – Dr. Kristin Weitzel of the UF Health Personalized Medicine Program outlines the benefits and challenges of training medical students to use genetic information in clinical practice.

University of Maryland incorporates pharmacogenomic testing in routine care for stent patients

Posted: January 6, 2017

The Baltimore Sun – Researchers and clinicians at the University of Maryland worked together to make CYP2C19 testing routine for stent patients, reducing the rate of adverse events such as death, heart attack, and stroke.

Sanford Heart Hospital develops routine pharmacogenetic testing process for cardiac patients

Posted: December 18, 2016

Keloland Media Group – Sanford Heart Hospital uses genetic testing to determine if clopidogrel is an effective blood thinner for its cardiac patients, an effort aided in part by work completed by IGNITE’s Dissemination, Outreach, and Sustainability Working Group.

Essentia Health promotes MeTree, a family health history tool developed by Duke University

Posted: December 12, 2016

Essential Health Daily Dose – In order to gain a better understanding of their personal health risks, Essentia Health encourages employees to use Thanksgiving as an opportunity to complete a family health history using Duke University’s MeTree tool.

Vanderbilt University receives historic NIH grant to become part of a prestigious national precision medicine program

Posted: December 5, 2016

VUMC Reporter – Vanderbilt University will serve as the Data and Research Support Center for the Precision Medicine Initiative Cohort Program with a five year, $71.6 million NIH grant, the largest of its kind Vanderbilt has received to date.

IGNITE researchers collaborate to improve patient outcomes through genomics

Posted: November 16, 2016

A collaborative IGNITE Network study shows that a quick, precise genetic test can significantly reduce the risk of cardiovascular events by helping to identify more effective medication for some heart patients. University of Florida researcher Larisa Cavallari, Pharm.D., presented these findings at the American Heart Association Scientific Sessions on Nov. 15, 2016.

University of Florida’s work on genetic testing to prevent complications for cardiac patients featured in Explore Magazine

Posted: November 15, 2016

Explore Magazine – IGNITE’s Dr. Julie Johnson explains the impact of translating the UF Health Personalized Medicine Program’s research on gene-drug responses to clopidogrel into a standard practice for interventional cardiology patients at UF Health.

IGNITE Network highlighted in the Journal of the American Medical Association

Posted: October 18, 2016

Journal of the American Medical Association – Duke University’s Dr. Geoffrey Ginsburg and University of Florida’s Dr. Julie Johnson discuss the value of and challenges facing the use of pharmacogenomics to improve patient care.

The Gainesville Sun spotlights the history and accomplishments of the UF Health Personalized Medicine Program

Posted: October 17, 2016

The Gainesville Sun – The University of Florida’s Dr. Julie Johnson and Dr. Larisa Cavallari discuss the trail the IGNITE Network’s UF Health Personalized Medicine Program has blazed in the field of precision medicine since its founding.

Duke University study uncovers clues as to how aspirin may help prevent colon cancer

Posted: September 26, 2016

The Duke Chronicle – Dr. Geoffrey Ginsburg of the Duke Center for Applied Genomics and Precision Medicine explains how aspirin’s mechanism of action may help prevent not just cardiovascular disease, but also colon cancer.

IGNITE Network’s Mia Levy participates in NCI summit on health IT policy

Posted: August 19, 2016

The American Journal of Managed Care – Dr. Mia Levy of the Vanderbilt Ingram Cancer Center describes opportunities for the successful dissemination and use of actionable health data for researchers and clinicians alike.

Mount Sinai obesity research featured in The New York Times

Posted: July 12, 2016

The New York Times – IGNITE Network’s Dr. Carol Horowitz works to reduce disparities in obesity and diabetes in underserved areas of New York City.

University of Florida researcher’s heart beats for pharmacogenomics

Posted: June 21, 2016

Genetic Engineering & Biotechnology News – Dr. Julie Johnson of the UF Health Personalized Medicine Program illuminates how current and future advancements in pharmacogenomic research can lead to additional improvements in the treatment of cardiovascular disease.

Vanderbilt University’s Mia Levy named Komen Scholar

Posted: April 12, 2016

Breast Cancer News – As one of the prestigious Komen Scholars, Dr. Mia Levy will help guide research and advocacy conducted by the Susan G. Komen Foundation.

Inaugural UF Precision Medicine Conference: A ‘pharmacogenomics army of champions’

Posted: April 5, 2016

Pharmacy Times – The University of Florida (UF) College of Pharmacy and the UF Health Personalized Medicine Program (PMP) recently hosted a Precision Medicine Conference and certificate training program for pharmacists in Orlando, Florida.

Duke University study emphasizes importance of family history in patient care

Posted: March 3, 2016

Duke Medicine News and Communications – Lead author Lori Orlando, M.D., showcases a Duke University study published in the Journal Genetics in Medicine that exposes both the expected and unexpected benefits of using MeTree, a web-based family health history tool.

NIH researchers identify genomic signature shared by five types of cancer

Posted: February 5, 2016

National Human Genome Research Institute – Researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. They also found evidence that this methylation signature may be present in many more types of cancer.

University of Florida hosts inaugural Precision Medicine Conference in Orlando, FL

Posted: December 15, 2015

University of Florida – The expanding role of pharmacogenomics in clinical medicine and education was the focus of the inaugural Precision Medicine Conference

IGNITE research in the spotlight in Florida news story

Posted: November 19, 2015

Business Report of Central North Florida – In the weeks and months after a patient gets a heart stent, blood clots can pose a major threat to recovery. Now, University of Florida Health researchers have found that a quick genetic test can tell doctors early on whether a crucial anti-clotting drug will work

IGNITE Network’s Josh Denny appointed to team of precision medicine experts for Obama

Posted: March 30, 2015

National Institutes of Health – A newly created team of experts in precision medicine and large clinical research studies will seek public input from the large and diverse stakeholder community interested in the development of the President’s Precision Medicine Initiative and articulate the vision for building the national participant group for the Initiative.

IGNITE newsletter features SPARK Toolbox, network updates

Posted: March 29, 2015

The IGNITE Network’s quarterly newsletter provides timely information on developments within the network with a specific focus on genomic implementation tools available for clinicians, researchers, health educators and patients.